➡️ Alcohol silences a key gut protein, letting harmful bacteria flood into the liver. Reactivating this pathway could protect against liver disease and offer new hope for treating alcohol dependence.
Alcohol-associated liver disease (ALD) is becoming one of the leading reasons people require liver transplants and one of the major causes of liver-related deaths around the world. The toll is rising quickly. In the United States alone, ALD resulted in an estimated $31 billion in annual costs in 2022. Projections suggest that by 2040, those costs could climb to $66 billion. Because current treatment options for ALD are limited, researchers are searching for new strategies that focus on the molecular processes driving the disease, with the goal of preventing it or reducing its progression.
➡️ Alcohol Disrupts a Key Gut Defense.
Researchers at the University of California, San Diego School of Medicine have identified how long-term alcohol consumption interferes with an important cellular signaling protein that helps keep gut bacteria contained within the intestinal tract. When this protective system weakens, those bacteria can move into the liver more easily, intensifying the damage caused by alcohol. The team suggests that targeting this biological pathway with drugs already available may help limit the liver injury associated with heavy alcohol use and lessen the overall impact of ALD.
➡️ What the Researchers Found
To explore this mechanism, the scientists examined human liver biopsy samples along with mouse models of ALD. Their findings showed the following:
⚫ Chronic alcohol use reduced the expression of muscarinic acetylcholine receptor M4 (mAChR4), a key cellular communication protein in the gut.
⚫ Reduced mAChR4 expression hindered the formation of goblet cell-associated antigen passages (GAPs), specialized structures that teach the immune system to promote antimicrobial immunity, thereby preventing harmful bacteria from migrating to the liver.
⚫ Restoring mAChR4 function, either by chemically activating mAChR4 or by targeting related signaling pathways allowed GAPs to form and conferred resistance to ALD.
➡️ Wider Implications for Alcohol-Related Disorders
Although the research centered on mAChR4 within the gut, this signaling protein is also known to influence areas of the brain involved in habit formation, learning and addiction. Because individuals with alcohol use disorder (AUD) tend to have lower mAChR4 expression in these brain regions, the findings may extend beyond liver disease.
Drugs that affect mAChR4 are already being tested in clinical trials for schizophrenia, and the scientists propose that such medications could potentially be repurposed for ALD and AUD. Additional studies will be needed to confirm whether this approach is viable.
© University of California - San Diego